Per Alfredsson ny vd för AstraZeneca i Sverige
AstraZeneca meddelar i dag att Per Alfredsson har utsetts till ny vd för AstraZeneca AB. Han tar över efter Katarina Ageborg från och med i dag den 9 januari.
-
-
AstraZeneca i unikt samarbete för att nå netto noll-utsläpp i vården
I dag tillkännager vd:arna för AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics och Sanofi gemensamma konkreta åtgärder för att snabba på omställningen till en hälso- och sjukvård med netto noll-utsläpp.
-
AstraZeneca shareholders vote in favour of proposed acquisition of Alexion
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
THIS IS AN ANNOUNCEMENT AND NOT A CIRCULAR OR PROSPECTUS OR EQUIVALENT DOCUMENT FOR THE PURPOSES OF THE UK PROSPECTUS REGULATION RULES OR THE UK AND EU PROSPECTUS REGUL -
Christer Betsholtz appointed new Head of Karolinska Institutet and AstraZeneca’s Integrated Cardio Metabolic Centre
Karolinska Institutet and AstraZeneca have today announced the appointment of Professor Christer Betsholtz as the new Director of their Integrated Cardio Metabolic Centre (ICMC) in Stockholm, Sweden.
Christer Betsholtz,PhD, is a leading scientific authority in the field of vascular biology with more than 300 publications. He is currently professor with tenure at Uppsala University and Karolinsk -
AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer
AstraZeneca today announced the appointment of Sean Bohen MD, PhD, as Executive Vice President of Global Medicines Development and Chief Medical Officer. He will join the company on 15 September.
Dr. Bohen will be responsible for driving the progress of AstraZeneca’s portfolio of small molecules and biologics investigational medicines through late-stage development to regulatory approval. As C -
AstraZeneca appoints Pam Cheng as Executive Vice President, Operations and IT
AstraZeneca today announced that Pam P. Cheng has joined the Company as Executive Vice President, Operations and IT.
-
AstraZeneca announces Non-Executive Board changes
AstraZeneca today announced that Dr Cornelia (Cori) Bargmann will be proposed to shareholders for election as a Non-Executive Director at the Company’s Annual General Meeting (AGM) on 24 April 2015.On election, the Board also proposes appointing Dr Bargmann to AstraZeneca’s Science Committee.
Cori is the Torsten N. Wiesel Professor and head of the Lulu and Anthony Wang Laboratory of Neural Circ -
Pascal Soriot utnämns till ny VD och koncernchef i AstraZeneca
AstraZeneca meddelar idag att Pascal Soriot har utnämnts till företagets VD och koncernchef. Pascal Soriot tillträder sin nya roll och blir anställd styrelseledamot (Executive Director) i AstraZenenecas styrelse den 1 oktober 2012.
